SCHEMBL9618778

SCHEMBL9618778

CCC1OC(=O)CC1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16843550 1.00
SCHEMBL14621016 0.83 SMN1; SMN2 (0.44)
SCHEMBL9172090 0.81 SMN1; SMN2 (0.43)
SCHEMBL114791 0.81 SMN1; SMN2 (0.43)
SCHEMBL7180354 0.81 SMN1; SMN2 (0.43)
SCHEMBL14994441 0.81 SMN1; SMN2 (0.43)
SCHEMBL7187580 0.81 SMN1; SMN2 (0.43)
SCHEMBL9171097 0.81 SMN1; SMN2 (0.43)
SCHEMBL7178100 0.81 SMN1; SMN2 (0.43)
SCHEMBL9171420 0.81 SMN1; SMN2 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170037078-A1 2' -DISUBSTITUTED NUCLEOSIDE ANALOGS FOR TREATMENT OF THE FLAVIVIRIDAE FAMILY OF VIRUSES AND CANCER COCRYSTAL PHARMA, INC. (US) 2017-02-09 US disclosed
EP-0153603-B1 THERMOSETTING RESIN COMPOSITION, CURED PRODUCT, AND PRODUCTION OF CURED PRODUCT HITACHI, LTD. (JP) 1992-01-02 EP disclosed